Document text
Principal Investigator: Iain Fraser
Organization: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Fiscal Year: 2022
Award: $72,177
Funding agency: National Institute of Allergy and Infectious Diseases
Cells of the innate immune system, such as dendritic cells and macrophages, constantly patrol host mucosal surfaces and peripheral tissues for signs of infection or injury. Since many people infected with SARS-CoV-2 clear the virus without developing symptoms, aspects of the innate immune response may hold the key to defeating this virus and its variants. The potential for an adverse cytokine storm depends on the interaction of different cell types at the site of infection. This highlights the need to study the immune response to SARS-CoV-2 in a combined environment of both epithelial cells, which are the primary target of infection, and innate immune cells such as macrophages, which are crucial drivers of inflammation.
In FY2022, we obtained access to the NIAID SARS Virology Core lab (SVC), and we have since established a co-culture assay with human epithelial cells, an established CoV-2-permissive cell, and human macrophages. Using an antibody specific to the SARS-CoV-2 spike protein, we have been able to measure viral infection of the epithelial cells and how this can be modulated by the macrophage state.
In a related project, we have investigated how biologically active small molecules can impart modulatory effects in immune cells, in some cases, providing extended long-term memory. In a screen of biologically active small molecules for regulators of TNF induction, we identified several compounds with the ability to induce training effects on human macrophages. Among these compounds, a Syk kinase inhibitor (SYKi IV) screen hit promoted an enhanced response to LPS similar to that previously reported for beta-glucan. Macrophages trained with SYKi IV showed a high degree of resistance to influenza A.
To extend these studies to coronavirus, we first determined that macrophages trained with SYKi IV showed reduced infection with the OC43 seasonal coronavirus. We then investigated effects in the epithelial/macrophage co-culture assays for SARS CoV-2, and found that SYKi IV macrophage training led to dramatically reduced epithelial cell infection. We find similar results with a broad panel of SYK kinase inhibitors, highlighting a potential application of SYK targeting as a modulator of SARS-CoV-2 susceptibility. This work was recently accepted for publication in Cell Reports.
We continue to evaluate the logistics of running large scale screen to identify gene perturbations or small molecules that can influence SARS-CoV-2 infection in the context of innate immune modulation.
We are also developing additional output assays to evaluate host cell responses to infection, such as multiplex high content microscopy-based single cell analysis of gene induction. Such assays can be conducted in fixed cells and as such, could be run outside the BSL-3 lab after the viral infection step.
Terms: <(TNF)-α><2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV S protein><2019-nCoV spike glycoprotein><2019-nCoV spike protein><Antibodies><Assay><B cell differentiation factor><B cell stimulating factor 2><B-Cell Differentiation Factor><B-Cell Differentiation Factor-2><B-Cell Stimulatory Factor-2><BCDF><BSF-2><BSF2><Bioassay><Biologic Assays><Biological Assay><Blood monocyte><Body Tissues><COVID crisis><COVID epidemic><COVID infected patient><COVID pandemic><COVID patient><COVID positive patient><COVID-19 S protein><COVID-19 assay><COVID-19 crisis><COVID-19 epidemic><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 infected patient><COVID-19 infection><COVID-19 pandemic><COVID-19 patient><COVID-19 positive patient><COVID-19 predisposition><COVID-19 public health crisis><COVID-19 spike glycoprotein><COVID-19 spike protein><COVID-19 susceptibility><COVID-19 therapy><COVID-19 treatment><COVID-19 virus><COVID-19 vulnerability><COVID19 S protein><COVID19 assay><COVID19 crisis><COVID19 epidemic><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 infection><COVID19 pandemic><COVID19 patient><COVID19 positive patient><COVID19 public health crisis><COVID19 spike glycoprotein><COVID19 spike protein><COVID19 therapy><COVID19 treatment><COVID19 virus><Cachectin><Cell Body><Cell Death><Cells><Cessation of life><Co-culture><CoV emergence><CoV-2><CoV2><Cocultivation><Coculture><Coculture Techniques><Coronaviridae><Coronaviridae Infections><Coronavirus><Coronavirus Infections><Coronavirus disease 2019 predisposition><Coronavirus disease 2019 susceptibility><Coronavirus disease 2019 vulnerability><Cytokines and Inflammatory Response><Death><Dendritic Cells><Disease><Disorder><Environment><Epithelial><Epithelial Cells><Extracellular Space><Genes><Goals><HPGF><Hepatocyte-Stimulating Factor><Host Factor><Host Factor Protein><Human><Hybridoma Growth Factor><IFN-beta 2><IFNB2><IL-6><IL6 Protein><Immune><Immune response><Immunes><Immunological response><Immunomodulation><Infection><Inflammation><Inflammatory><Inflammatory Response><Inflammatory Response Pathway><Influenza A><Influenza A virus><Influenza Viruses Type A><Influenzavirus A><Injury><Innate Immune Response><Innate Immune System><Integration Host Factors><Intercellular Space><Interleukin-6><Logistics><Lung><Lung Respiratory System><MGI-2><Macrophage-Derived TNF><Marrow monocyte><Measures><Microscopy><Modern Man><Monocyte-Derived TNF><Mucosa><Mucosal Tissue><Mucous Membrane><Myeloid Differentiation-Inducing Protein><Mφ><NIAID><National Institute of Allergy and Infectious Disease><Orthomyxovirus Type A><Output><Peripheral><Persons><Plasmacytoma Growth Factor><Predisposed to COVID-19><Predisposed to SARS-CoV-2><Predisposed to Severe acute respiratory syndrome coronavirus 2><Publications><Reporting><Resistance><Running><SARS><SARS corona virus 2><SARS coronavirus disease><SARS-CO-V2><SARS-COVID-2><SARS-CoV disease><SARS-CoV-2><SARS-CoV-2 S protein><SARS-CoV-2 assay><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 infected patient><SARS-CoV-2 infection><SARS-CoV-2 pandemic><SARS-CoV-2 patient><SARS-CoV-2 positive patient><SARS-CoV-2 predisposition><SARS-CoV-2 spike glycoprotein><SARS-CoV-2 spike protein><SARS-CoV-2 susceptibility><SARS-CoV-2 therapy><SARS-CoV-2 treatment><SARS-CoV-2 vulnerability><SARS-CoV2><SARS-CoV2 S protein><SARS-CoV2 epidemic><SARS-CoV2 infection><SARS-CoV2 pandemic><SARS-CoV2 spike glycoprotein><SARS-CoV2 spike protein><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><SYK><SYK gene><Sampling><Scientific Publication><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome CoV disease><Severe Acute Respiratory Syndrome coronavirus disease><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 S protein><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 predisposition><Severe acute respiratory syndrome coronavirus 2 spike glycoprotein><Severe acute respiratory syndrome coronavirus 2 spike protein><Severe acute respiratory syndrome coronavirus 2 susceptibility><Severe acute respiratory syndrome coronavirus 2 vulnerability><Severe acute respiratory syndrome related corona virus 2><Site><Spleen Tyrosine Kinase><Surface><Symptoms><TNF><TNF A><TNF Alpha><TNF gene><TNF-α><TNFA><TNFα><Tissues><Training><Tumor Necrosis Factor><Tumor Necrosis Factor-alpha><Type A Influenza><Tyrosine-Protein Kinase SYK><Variant><Variation><Veiled Cells><Viral><Viral Diseases><Virion><Virus><Virus Diseases><Virus Particle><Virus Replication><Work><Wuhan coronavirus><adverse consequence><adverse outcome><base><beta-Glucans><cell type><corona virus><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><corona virus emergence><coronavirus disease 2019 S protein><coronavirus disease 2019 assay><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 infected patient><coronavirus disease 2019 infection><coronavirus disease 2019 pandemic><coronavirus disease 2019 patient><coronavirus disease 2019 positive patient><coronavirus disease 2019 public health crisis><coronavirus disease 2019 spike glycoprotein><coronavirus disease 2019 spike protein><coronavirus disease 2019 therapy><coronavirus disease 2019 treatment><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease infected patient><coronavirus disease pandemic><coronavirus disease patient><coronavirus disease positive patient><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 patient><coronavirus disease-19 virus><coronavirus emergence><coronavirus patient><cytokine><cytokine release syndrome><cytokine storm><emergent CoV><emergent corona virus><emergent coronavirus><emerging CoV><emerging corona virus><emerging coronavirus><gene induction><hCoV19><host response><immune modulation><immune regulation><immune system response><immunologic reactivity control><immunomodulatory><immunoregulation><immunoregulatory><immunoresponse><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><injuries><interferon beta 2><kinase inhibitor><long term memory><longterm memory><macrophage><monocyte><nCoV><nCoV2><necrocytosis><new CoV><new corona virus><new coronavirus><novel CoV><novel corona virus><novel coronavirus><patient infected with COVID><patient infected with COVID-19><patient infected with SARS-CoV-2><patient infected with coronavirus disease><patient infected with coronavirus disease 2019><patient infected with severe acute respiratory syndrome coronavirus 2><patient with COVID><patient with COVID-19><patient with COVID19><patient with SARS-CoV-2><patient with coronavirus disease><patient with coronavirus disease 2019><patient with severe acute respiratory distress syndrome coronavirus 2><predisposed to Coronavirus disease 2019><pulmonary><recruit><resistant><response><screening><seasonal coronavirus><severe acute respiratory syndrome coronavirus 2 assay><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 infected patient><severe acute respiratory syndrome coronavirus 2 patient><severe acute respiratory syndrome coronavirus 2 positive patient><severe acute respiratory syndrome coronavirus 2 therapy><severe acute respiratory syndrome coronavirus 2 treatment><single cell analysis><small molecule><susceptible to COVID-19><susceptible to Coronavirus disease 2019><susceptible to SARS-CoV-2><susceptible to Severe acute respiratory syndrome coronavirus 2><therapeutic target><treat COVID-19><treat COVID19><treat SARS-CoV-2><treat coronavirus disease 2019><treat severe acute respiratory syndrome coronavirus 2><viral infection><viral multiplication><viral replication><virology><virus infection><virus multiplication><virus-induced disease><β-Glucans>